Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Kislay Roy
Sign up to set email alerts
50
Publications
611
Citation Statements Received
1,694
Citation Statements Given
How they've been cited
1,014
13
597
1
How they cite others
2,145
47
1,641
6
Affiliations
Deakin University
,
Georgia Institute of Technology
Publications
Order By: Most citations
Fe-Blf Nanoformulation Targets Survivin to Kill Colon Cancer Stem Cells and Maintains Absorption of Iron, Calcium and Zinc
Kanwar
1
,
Mahidhara
2
,
Roy
3
et al.
2014
Nanomedicine (Lond.)
70
4
93
1
Get access via publisher
Add to collection
Cite
Multifunctional Iron Bound Lactoferrin and Nanomedicinal Approaches to Enhance Its Bioactive Functions
Kanwar
1
,
Roy
2
,
Patel
3
et al.
2015
Molecules
Abstract
Show
139
0
86
0
Get access via publisher
Add to collection
Cite
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
Macdonald
1
,
Henri
2
,
Roy
3
et al.
2018
Cancers
Abstract
Show
76
0
68
0
Get access via publisher
Add to collection
Cite
Chimeric aptamers in cancer cell-targeted drug delivery
Kanwar
1
,
Roy
2
2011
Critical Reviews in Biochemistry and Molecular Biology
Abstract
Show
137
0
67
0
Get access via publisher
Add to collection
Cite
LNA aptamer based multi-modal, Fe 3 O 4 -saturated lactoferrin (Fe 3 O 4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging
Roy
1
,
Kanwar
2
2015
Biomaterials
88
0
40
0
1
Get access via publisher
Add to collection
Cite
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition
Edwards
1
,
Kanwar
2
,
Roy
3
et al.
2015
Chem. Commun.
Abstract
Show
56
0
40
0
Get access via publisher
Add to collection
Cite
Applications of Aptamers in Nanodelivery Systems in Cancer, Eye and Inflammatory Diseases
Kanwar
1
,
Mohan
2
,
Roy
3
et al.
2010
Nanomedicine
40
0
31
0
Get access via publisher
Add to collection
Cite
Recent Advances in Nanomedicine and Survivin Targeting in Brain Cancers
Mazur
1
,
Roy
2
,
Kanwar
3
2017
Nanomedicine (Lond.)
Abstract
Show
47
0
27
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6
7